chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 or 6 hours after immunization, he felt weak, SOB and became incontinent.  Also had fever.  This continues throughout the night and in the morning he was fine.
First 24 hours:  Chills, fever, vomiting, unable to keep anything down (even water) for the entire day after the vaccine was given, body aches Second 24 hours:  Chills, nausea, fever, body aches Third 24 hours:  fatigue, some nausea, occasional chills, body aches Fourth 24 hours:  fatigue Finally ALL better!
Patient began to have chest pains, SOB, feeling flushed and tingling down both arms.  EMS began with heart monitor on patient.   EKG WNL  B./P 140/97,  HR  57   o2 Sat 100 %Ambulance transported patient to Hospital.
So out of it; Feel like I am going to fall on my face; Extremely dizzy; Eyes burning; Ringing in ears; Hot and swollen; Hot and swollen; Chills; Temperature went up to 100.3; Headache; Out of breath; A spontaneous report (United States) was received from a healthcare professional concerning a 60-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events, being so out of it, hot and swollen at injection site, headache, temperature went up to 100.3 F, ringing in ears, eyes burning, out of breath, extremely dizzy, chills, and feel like I am going to fall on my face.    The patient's medical history included a positive COVID-19 diagnosis in April 2020. Products known to have been used by the patient, within two weeks prior to the event, included baclofen, duloxetine, two blood pressure medications, one medication for anxiety, potassium, meloxicam, and nortriptyline.   On 05 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 039K20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On an unknown date, following vaccine administration, the patient was so out of it and felt like she was going to fall on her face.  On  06 Jan 2021, the patient's injection site was hot and swollen.  She reported that she had a headache and fever and there was ringing in her ears.  Her eyes burned, she was extremely dizzy, and had chills. Treatment for the event included paracetamol and sumatriptan.   Action taken with mRNA-1273 in response to the events was not provided.   The events, being so out of it, hot and swollen at injection site, headache, temperature went up to 100.3 F, ringing in ears, eyes burning, out of breath, extremely dizzy, chills and feel like I am going to fall on my face, were considered resolving.; Reporter's Comments: This case concerns a 60-year-old female patient who received their first of two planned doses of mRNA-1273 (Lot 039K20A), and who experienced the non-serious listed events of Injection site swelling, Chills, Pyrexia, and Headache, and the non-serious unlisted events of Dyspnoea, Disorientation, Balance disorder, Dizziness, Eye irritation, Tinnitus, and Injections site warmth.  Very limited information regarding the events has been provided at this time.  Based on the current available information and temporal association between vaccination and the onset of events starting on the day of vaccination, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.
Radiating soreness, on arm, back, up to shoulder and neck.   Patient has gone to urgent care and received anti-inflammatory and muscle relaxer. MD believes the severity of his reaction to be an anomaly.  This reaction has put limitations on his movements and plans and he came to me at work wanting to report this to the developer of the vaccine.   I counselled him and we discussed his symptoms and I agreed to report this for him.
Patient report that she has serve headaches that started the day after... 4 days later she was vomiting (has stopped now)... 3 days after she started to get itchy red bumps on both feet
Pain at injection site  immediately after injection and continues to this day  Arm can't move (literally first 4 months could not move arm)  Loss of feeling in fingers (Immediately after injection and ongoing)  Incredible pain ( first 3 months , getting less intense. Still ongoing)  My useless doctor that poisoned me has ordered no tests. I got physical therapy   Seeing as that is the cure all for SIRVA related to the poison you sell.
morbilliform; skin is still red/skin is still splotchy with occasional flare ups; pretty severe rash on most of their trunk/rash on shoulders/ rash on neck; rash down the arms; itchy rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH MORBILLIFORM (morbilliform), ERYTHEMA (skin is still red/skin is still splotchy with occasional flare ups), RASH (pretty severe rash on most of their trunk/rash on shoulders/ rash on neck), VACCINATION SITE RASH (rash down the arms) and VACCINATION SITE PRURITUS (itchy rash) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MORBILLIFORM (morbilliform), ERYTHEMA (skin is still red/skin is still splotchy with occasional flare ups), RASH (pretty severe rash on most of their trunk/rash on shoulders/ rash on neck), VACCINATION SITE RASH (rash down the arms) and VACCINATION SITE PRURITUS (itchy rash). At the time of the report, RASH MORBILLIFORM (morbilliform), ERYTHEMA (skin is still red/skin is still splotchy with occasional flare ups), RASH (pretty severe rash on most of their trunk/rash on shoulders/ rash on neck), VACCINATION SITE RASH (rash down the arms) and VACCINATION SITE PRURITUS (itchy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
p/vax pt ran fever & devel lacy all over body; fever lasted 4 days; ranged from 101-104
Employee indicated that she did not know if the vaccine went in. Vaccine squirted out and patient had droplets of vaccine on arm. Patient was not given further instruction and nothing was reported.
Body aches/ Over all pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of GENERAL PHYSICAL CONDITION NORMAL (Body aches/ Over all pain) and HEADACHE (Headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced GENERAL PHYSICAL CONDITION NORMAL (Body aches/ Over all pain) (seriousness criterion medically significant) and HEADACHE (Headache) (seriousness criterion medically significant). At the time of the report, GENERAL PHYSICAL CONDITION NORMAL (Body aches/ Over all pain) and HEADACHE (Headache) outcome was unknown.            The patient was having body aches, headache, over all pain and still on going as of 30 Apr 2021. No concomitant medication No treatment medication  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information has been received from a medical assistant concerning to a 10 week old patient (gender not reported). Current conditions, medical history and concomitant medications were not reported. On 08-SEP-2017, the patient was inadvertently vaccinated with a dose of VAQTA (lot number and expiration date not reported), 0.5 ml, intramuscular for prophylaxis instead of hepatitis b vaccine (manufacturer unknown). No adverse event was reported.
All over body aches night of receiving shot. Day after, large red, swollen, warm area around injection site. Few inches in diameter present today.
Patient inadvertently received Hep B vaccine.   Patient was due to receive Dtap and Hep A vaccines which was later administered to comply with school entrance immunization requirements.  No adverse reactions.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Vaccine was administered after 24 hours of first puncture  No concomitant medications was reported. Treatment medications was not provided.   This case was linked to MOD-2021-332638 (Patient Link).
got a bad case of the shingles four years after your taking your vaccine/ Suspected Vaccination failure; Shingles; This serious case was reported by a consumer and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 4 years after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: got a bad case of the shingles four years after your taking your vaccine/ Suspected Vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 25-JUN-2023 The reporter wanted to know he/she just got a bad case of the shingles four years after taking shingles vaccine.  The reporter wanted to know what he/she should do and any recommendation or any treatments. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting.
Information has been received from a registered nurse concerning a 6 year old white male with no known drug allergies and no past medical history who on 2/17/98 was vaccinated IM in the left lower thigh with a first dose of varicella virus vaccine live (Lot # 621191/1549D). There was no illness at the time of vaccination. Concomitant vaccinations that day included a first dose of MMR (lot # 621288/1010E) administered SC in the right lower thigh, a third dose of hepatitis B virus vaccine (lot # 623069/0158E) administered IM in the right lower thigh, a fourth dose of diphtheria toxoid (+) Haemophilus B conjugate vaccine (+) pertussis vaccine (+) tetanus toxoid (batch # 439 192) administered IM in the left lower thigh, and a third dose of poliovirus vaccine (batch # T0816-2) administered SC in the right lower thigh. On 6/30/03 the mother reported that her child had chicken pox. It was described as lots of pox on back, arms, upper legs, and face. There were no adverse events following prior vaccinations of the patient or his siblings. Follow up information indicated that the child had an uneventful recovery. The pox on the back, upper arms, neck, and chest lasted about 1 week. He also had a low grade temperature in the evenings. There were no lasting effects from the disease. The outcome was reported as recovered. No further information is expected.
PATIENT EXPERIENCED ITCHING APPROX 2 WEEKS AFTER VACCINE AND NOTICED A LUMP UNDER THE SKIN.  SHE HAD IT CHECKED AND IT ENDED UP BEING SQUAMOUS CELL CARCINOMA.  PER THE PATIENT, THE MD DOESN'T THINK IT WAS FROM VACCINE ITSELF BUT POSSIBLY CELL ACCUMULATION AT THE INJECTION SITE.  SHE HAD SURGERY TO REMOVE IT.  THE MD RECOMMENDED WE GIVE THE SECOND DOSE, WHICH SHE RECEIVED ON 7/19/19
Approximately 12 hours after receiving Tdap she had severe (L) arm pain, nausea, chills and fatigue. One day after receiving Tdap she reported (L) shoulder "felt like someone was cutting it off" and every muscle and bone hurt." By 4/30/07 symptoms improving but had headache.
pt recv vax 10NOV97 & 21NOV97 pt devel chickenpox consisting of 12-14 raised & inflamed lesions, w/crusting & itching;pt LMP was 27JUL97;expected date of delivery is 3APR98;
This spontaneous report as received from a Medical Assistant refers to 8 weeks old infant, gender not reported. On 19-NOV-2014, the patient was vaccinated with ROTATEQ, lot # K009181, orally. It was reported that the administered vaccine was subject to temperature excursion during storage. No adverse event was reported. This is one of the several reports from the same reporter. Additional information has been requested.
8/3/16--9:30 a.m.Patient fainted briefly (less than 1 minute) immediately after vaccinations given while still seated in chair.  Mom & nurses assisted with cold packs & wet paper towels on neck, face, and arms.  At no time did patient fall to the floor.  Patient was offered cold water and took a few sips & also began to lick on the lollipop offered.  After 10 minutes, patient was offered cold Sprite and began to sip it, holding the can himself.  After approximately 15 minutes patient regained color in his face and neck, mom and nurses assisted him to waiting room where he laid down on table.  Nurse  offered to call 911 to have paramedics come and evaluate patient, but mother adamantly refused.  Patient and family was advised to not let patient drive until he returned to normal and to take all the time needed to rest.  Nurse, patient's mom & sisters assisted patient with cold packs while patient continued to lick lollipop while lying on table. At 10:10 mother determined that patient was well enough to sit up, so patient sat on table for 5 minutes, then walked slowly around waiting room.  At 10:17 family members and patient told Nurse that patient was felling normal again, and all family members including patient ambulated normally out of building.  Family and patient thanked Nurse for assistance given.
Flu vaccine with H1N1 shot at 12:30pm - 9/30/2010 - 9/30/2010 12:40pm couldn't swallow - had difficulty breathing - rushed to E.R. for treatment - had care -several drugs for 2hr - released with EPIPEN - BENADRYL & Prednisone.
Irritability starting 4-6 hours after shot. No severe fever and local swelling, redness, warmth, tenderness lasts 2-4 hrs. resolved.
Papular like rash started 8/9 in the morning under breasts and spread through the day towards her back. Sunday 8/10 papules appeared near her armpit. ER doctor stated it was shingles.
Pt received PREVNAR and FLUZONE HD, and complained that her entire arm became sore.
Patient stated he had a rash about 4 inches in diameter on Left arm after receiving COVID booster, instead of the Bivalent. Patient states the rash was itchy but denied any bumps or soreness. Patient states that he did not take any medications and the rash went away on it's own after 3 days.
I had slight cough, body ache, and headache for a couple days. I also had a fever for about a day. The headache is still ongoing since August. I tested positive for Covid-19 on Aug 23rd. I got the antibodies infusion on Aug 29th. I went to my doctor about the headaches. They did a MRI, normal results. He also referred me to see a neurologist.
On April 4, 2021 at about 1:00pm, I had a tonic-clonic seizure. Beforehand, I saw painful flashing lights in my eyes and leaned against a wall to brace myself. Witnesses reported that I fell hard to the ground and gashed my head, bit my tongue, and had convulsions in my arms and legs. Due to the unexpected nature of the event. witnesses were unsure who long it lasted, but they estimated about two minutes. Afterwards, I was transported by ambulance to the emergency room where I had a CT scan and blood tests.
rash, same "shingles rash" he had in the same place 40 years earlier; This case was reported by a pharmacist via call center representative and described the occurrence of vesicular rash in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had 40 years earlier).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 2 weeks after receiving Shingrix, the patient experienced vesicular rash. On an unknown date, the outcome of the vesicular rash was recovered/resolved.   It was unknown if the reporter considered the vesicular rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 20-APR-2022 Reporter's Comments: The patient was given 1st dose of Shingrix and two weeks later, the patient developed a rash.  The reporter stated that the patient told it was the same shingles rash he had in the same place 40 years earlier. The reporter refused to answer any further questions and she was too busy.  The reporter did not consent to follow-up.
Terrible Headaches, muscle pain, dizziness, nausea, stomach pain, chest pain, and rash around my torso, front and back.
Administered expired vaccines to patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccines to patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccines to patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccines to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.
Fully vaccinated patient who tested positive for COVID during admission testing.  Discharging providers note:  "66 YO female with h/o rheumatoid arthritis on methotrexate, hypertension, and hyperlipidemia who presented to the emergency department for evaluation of abdominal pain initially thought to have pancreatitis in the setting of fairly elevated lipase; however, more likely due to side effect from recent rituximab infusion.  Treated initially with IV fluids, pain control, and nothing by mouth; however, graduated pre rapidly to full liquid diet and resolution of pain.  She still had some residual abdominal pain with solid foods, so decided to keep 1 more day to evaluate with resolution of post meal abdominal pain on the day of discharge.  She did test positive for COVID upon admission, but did not have any hypoxia or shortness and breath, rather minimal dry cough (did receive Regeneron).  Initially was hypotensive upon admission with resolution upon day of discharge, but she is on multiple antihypertensive medications, so instructed her to hold her blood pressure medications with daily blood pressure monitoring until follow-up with her primary care doctor."
Fever, chills for approx. 3 days. Rapid pulse (110), rapid breathing and wheezing. I got hoarse. I considered going to hospital, but felt there was nothing they could do. Your website does not indicate if there was any remedy.
Information has been received from a physician via a company representative concerning a patient (age not provided) with unknown medical history and unknown drug allergies who on an unspecified date was vaccinated subcutaneously with 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot # unknown). subsequently, the patient developed enlarged liver and spleen. The patient's outcome was not reported. There was no product quality complaint involved. Additional information has been requested.
Received Hepatitis B vaccination (ENGERIX B) on 7-14-09. Returned for dose #2 Hep B today 8-14-09. That's when the patient showed nurse a papule/pustule like knot on (L) arm at inj site of previous dose. No redness. Non-tender 4-5mm circumference. Elevated 2mm. Non-draining.
Initial and follow up information has been received from a consumer, concerning her 6 month old daughter with no pertinent medical history, drug reactions/allergies or concomitant medication use, who in July or August 2007 was vaccinated (site and route not reported) with the 1st dose of the Hib conj vaccine (OMPC) (lot# 656520/0435U). The patient was vaccinated with other vaccines on the same day as the Hib conj vaccine was given but mother can not recall which ones. The patient's mother reported that "right after Hib conj vaccine the patient developed a fever that lasted about 3 to 5 days". The patient did receive unspecified medical attention, no diagnostic lab test were performed. On a unspecified day the patient recovered from the fever. Follow up information received from the physician indicated that he was not aware of an adverse event, and indicated the child had no reaction. The child also had no illness at the time of vaccination, and no pertinent medical history. He reported the child was fine and had "no issue," though he confirmed the child was vaccinated on 03-OCT-2007, with lot # 656520/0435U, as reported above, from a recalled lot. Additional information is not expected.
No adverse event; Patient received expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 60-year-old female patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine).    The NDC ID was reported as 80777027398.  Person number was reported as 159617.  No concomitant medications were reported.  Order date and completion date was reported as 09-Jun-2022.  The vaccine from the vial with lot number O70H21A was administered to the patient in between a period of 08-Apr-2022 to 15-Dec-2022.  It was reported that also another past lot of vaccines with lot number 065F21A was also previously expired and administered to patients.  No treatment medications were reported.